{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T01:55:44Z","timestamp":1712109344293},"reference-count":29,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Improved survival after breast cancer treatment comes at a cost in the form of increased risk of late effects. A number of these are summarised in this review. The late effects can be divided in 1) late effects after locoregional treatment, e.g., lymphoedema, impaired shoulder movement, and pain; 2) consequences of systemic treatment, e.g. polyneuropathy, problems related to premature menopause, and increased risk of cardio-vascular disease; and 3) general late effects, commonly seen across all cancer types, including fatigue, insomnia, and cognitive impairment. There is a need for more knowledge about risk factors, prognoses, and the most effective treatments.<\/jats:p>","DOI":"10.61409\/v02230091","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T12:02:21Z","timestamp":1712059341000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Late effects following breast cancer treatment"],"prefix":"10.61409","volume":"186","author":[{"given":"Anders Bonde","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peer","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille","family":"Bech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"ref0","unstructured":"Zachariae B, Mehlsen M, red. Livet efter kr\u00e6ft - senf\u00f8lger og andre udfordringer efter afsluttet kr\u00e6ftbehandling. FADL's Forlag, 2020."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"DiSipio T, Rye S, Newman B et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500-15. doi: https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","DOI":"10.1016\/S1470-2045(13)70076-7"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Johnson AR, Kimball S, Epstein S et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82(4S Suppl 3):S234-S241. Doi: https:\/\/doi.org\/10.1097\/SAP.0000000000001864","DOI":"10.1097\/SAP.0000000000001864"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Bartels SAL, Donker M, Poncet C et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS Trial. J Clin Oncol. 2023;41(12)2159-2165. doi: https:\/\/doi.org\/10.1200\/JCO.22.01565","DOI":"10.1200\/JCO.22.01565"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Smile TD, Tendulkar R, Schwarz G et al. A review of treatment for breast cancer-related lymphedema. Am J Clin Oncol. 2016;41(2):178-190. doi: https:\/\/doi.org\/10.1097\/COC.0000000000000355","DOI":"10.1097\/COC.0000000000000355"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Todd M. Identification, assessment and management of breast oedema after treatment for cancer. Int J Palliat Nurs. 2017;23(9):440-444. Doi: https:\/\/doi.org\/10.12968\/ijpn.2017.23.9.440","DOI":"10.12968\/ijpn.2017.23.9.440"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Elson L. Chapter 110 - Post-mastectomy pain syndrome. I: Frontera WR, Silver JK, Rizzo TD. Essentials of physical medicine and rehabilitation (fourth ed.) Elsevier, 2020:604-607. doi: https:\/\/doi.org\/10.1016\/B978-0-323-54947-9.00110-3","DOI":"10.1016\/B978-0-323-54947-9.00110-3"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Juhl AA, Karlsson P, Damsgaard TE. Fat grafting for alleviating persistent pain after breast cancer treatment: a randomized controlled trial. J Plast Reconstr Aesthet Surg. 2016:69(9):1192-202. Doi: https:\/\/doi.org\/10.1016\/j.bjps.2016.07.003","DOI":"10.1016\/j.bjps.2016.07.003"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Bandos H, Melnikov J, Rivera DR et al. Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG Oncology\/NSABP B-30. J Natl Cancer Inst. 2018;110(2):djx 162. Doi: https:\/\/doi.org\/10.1093\/jnci\/djx162","DOI":"10.1093\/jnci\/djx162"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Smith EML, Pang H, Cirrincione C et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013;309(13):1359-67. doi: https:\/\/doi.org\/10.1001\/jama.2013.2813","DOI":"10.1001\/jama.2013.2813"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Hammond EA, Pitz M, Steinfeld K et al. An exploratory randomized trial of physical therapy for the treatment of chemotherapy-induced peripheral neuropathy. Neurorehabil Neural Repair. 2020;34(3):235246. doi: https:\/\/doi.org\/10.1177\/1545968319899918","DOI":"10.1177\/1545968319899918"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Johannsen M, Farver I, Beck N, Zachariae R. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138(3:)675-690. doi: 10.1007\/s10549-0. Doi: https:\/\/doi.org\/10.1007\/s10549-013-2503-4","DOI":"10.1007\/s10549-013-2503-4"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Fogh M, H\u00f8jgaard A, Rotb\u00f8l CB, Jensen AB. The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study. Acta Oncol. 2020;60(1):61-68. doi: https:\/\/doi.org\/10.1080\/0284186X.2020.1813326","DOI":"10.1080\/0284186X.2020.1813326"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Hadji P, Gnant M, Body JJ et al. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? Cancer Treat Rev. 2012;38(6):798-806. doi: https:\/\/doi.org\/10.1016\/j.ctrv.2012.02.008","DOI":"10.1016\/j.ctrv.2012.02.008"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Duijts SF, van Beurden M, Oldenburg HS et al. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol. 2012;30(33):4124-33. doi: https:\/\/doi.org\/10.1200\/JCO.2012.41.8525","DOI":"10.1200\/JCO.2012.41.8525"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Nowsheen S, Viscuse PV, O'Sullivan CC et al. Incidence, diagnosis, and treatment of cardiac toxicity from trastuzumab in patients with breast cancer. Curr Breast Cancer Rep. 2017;9(3):173-182. doi: https:\/\/doi.org\/10.1007\/s12609-017-0249-4","DOI":"10.1007\/s12609-017-0249-4"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Fredslund SO, Laursen BE, Gravholt C, Jensen AB. Key metabolic parameters change significantly in early breast cancer survivors: an exploratory PILOT study. J Transl Med. 2019;17(1):105. doi: 10.1186\/s12967-019-1850-2. doi: https:\/\/doi.org\/10.1186\/s12967-019-1850-2","DOI":"10.1186\/s12967-019-1850-2"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Christensen S, Zachariae R, Jensen AB et al. Prevalence and risk of depressive symptoms 3-4months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat. 2009;113(2):339-355. doi: https:\/\/doi.org\/10.1007\/s10549-008-9920-9","DOI":"10.1007\/s10549-008-9920-9"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Dijkshoorn ABC, van Stralen HE, Sloots M et al. Prevalence of cognitive impairment and change in patients with breast cancer: a systematic review of longitudinal studies. Psychooncology. 2021;30(5):635-648. Doi: https:\/\/doi.org\/10.1002\/pon.5623","DOI":"10.1002\/pon.5623"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Leysen L, Lahousse A, Nijs J et al. Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses. Support Care Cancer. 2019;27(12):4401-4433. doi: https:\/\/doi.org\/10.1007\/s00520-019-04936-5","DOI":"10.1007\/s00520-019-04936-5"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Colagiuri B, Christensen S, Jensen AB et al.. Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery. J Pain Symptom Manage. 2011;42(5):710-720. doi: https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.02.012","DOI":"10.1016\/j.jpainsymman.2011.02.012"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Abrahams HJ, Gielissen MF, Schmits IC et al.. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol. 2016;27(6):965-974. Doi: https:\/\/doi.org\/10.1093\/annonc\/mdw099","DOI":"10.1093\/annonc\/mdw099"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Johannsen M, Christensen S, Zachariae R, Jensen AB. Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7-9 years after surgery: a nationwide prospective study of women treated for primary breast cancer. Breast Cancer Res Treat. 2015;152(3):645-658. Doi: https:\/\/doi.org\/10.1007\/s10549-015-3497-x","DOI":"10.1007\/s10549-015-3497-x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Luigjes-Huizer YL, Tauber NM, Humphris G et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? Psychooncology. 2022;31(6):879-892. doi: https:\/\/doi.org\/10.1002\/pon.5921","DOI":"10.1002\/pon.5921"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nielsen AWM, Kristensen MH, Offersen BV et al.. Patient-reported outcomes in postmenopausal breast cancer survivors - comparisons with normative data. Acta Oncol. 2021;60(1):78-86. Doi: https:\/\/doi.org\/10.1080\/0284186X.2020.1834143","DOI":"10.1080\/0284186X.2020.1834143"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Cillessen L, Johannsen M, Speckens AEM, Zachariae R. Mindfulness-based interventions for psychological and physical health outcomes in cancer patients and survivors: a systematic review and meta-analysis of randomized controlled trials. Psychooncology. 2019;28(12):2257-2269. Doi: https:\/\/doi.org\/10.1002\/pon.5214","DOI":"10.1002\/pon.5214"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Tauber NM, O'Toole MS, Dinkel A et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899-2915. Doi: https:\/\/doi.org\/10.1200\/JCO.19.00572","DOI":"10.1200\/JCO.19.00572"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Johnson JA, Rash JA, Campbell TS et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016;27:20-28. doi: https:\/\/doi.org\/10.1016\/j.smrv.2015.07.001","DOI":"10.1016\/j.smrv.2015.07.001"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zachariae R, Amidi A, Damholdt MF et al. Internet-delivered cognitive-behavioral therapy for insomnia in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst. 2018;110(8):880-887. doi: https:\/\/doi.org\/10.1093\/jnci\/djx293","DOI":"10.1093\/jnci\/djx293"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T13:49:00Z","timestamp":1712065740000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V02230091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":29,"URL":"https:\/\/doi.org\/10.61409\/v02230091","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}